Multimodality treatment paradigms for renal cell carcinoma: surgery versus targeted agents.Published in:2009Publication type:Abstract
Metastatic renal cell carcinoma risk according to tumor size.Published in:2009Publication type:Abstract
A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer.Published in:2009Publication type:Abstract
Laparoscopic surgery on upper urinary tract in children younger than 1 year: technical aspects and functional outcome.Published in:2009Publication type:Abstract
Growth hormone treatment started in the first year of life in infants with chronic renal failure.Published in:2009Publication type:Abstract
Sonographic long-term study: paediatric growth charts for single kidneys.Published in:2009Publication type:Abstract
Meta-analysis: does lidocaine gel before flexible cystoscopy provide pain relief?Published in:2009Publication type:Abstract
Residual renal function and nutrition in young patients on chronic hemodialysis.Published in:2009Publication type:Abstract
Partial nephrectomy versus radical nephrectomy in patients with small renal tumors - is there a difference in mortality and cardiovascular outcomes?Published in:2009Publication type:Abstract
Renal insufficiency is not a contraindication for cryoablation of small renal masses.Published in:2009Publication type:Abstract
Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).Published in:2009Publication type:Abstract
Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma.Published in:2009Publication type:Abstract
Synergistic effect of sorafenib and sunitinib with enzastaurin, a selective protein kinase C inhibitor in renal cell carcinoma cell lines.Published in:2009Publication type:Abstract
Toxicity associated with the long-term use of targeted therapies in patients with advanced renal cell carcinoma.Published in:2009Publication type:Abstract
Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.Published in:2009Publication type:Abstract
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.Published in:2009Publication type:Abstract
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.Published in:2009Publication type:Abstract
Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival.Published in:2009Publication type:Abstract
Antitumor efficacy of recombinant human interleukin-2 combined with sorafenib against mouse renal cell carcinoma.Published in:2009Publication type:Abstract
Sunitinib treatment in patients with severe renal function impairment: a report of four cases by the Hellenic Cooperative Oncology Group.Published in:2009Publication type:Abstract
Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III Treatment Approaches in Renal Cancer Global Evaluation Trial.Published in:2009Publication type:Abstract
Probe Ablation for Treatment of Localized Renal Cell Carcinoma.Published in:Current Medical Literature: Kidney Cancer, 2009, v. 1, n. 4, p. 97By:Kutikov, Alexander;Uzzo, Robert G.;Chen, David Y. T.Publication type:Article
Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis.Published in:2009Publication type:Abstract
Foreword.Published in:Current Medical Literature: Kidney Cancer, 2009, v. 1, n. 4, p. 97Publication type:Article